Registry for better diabetes care in children and adolescents
Better Control in Pediatric and Adolescent diabeteS: Working to crEate CEnTers of Reference
This study is trying to see how well different treatment approaches work for kids and teens with Type 1 Diabetes to help them get better care and enjoy their childhood.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100000 (estimated) |
| Sex | All |
| Sponsor | Kinderkrankenhaus auf der Bult Academic / other |
| Locations | 1 site (Hanover, Low Saxony) |
| Trial ID | NCT04427189 on ClinicalTrials.gov |
What this trial studies
The SWEET-Registry is a multi-center observational registry aimed at improving the quality of care for children and adolescents with Type 1 Diabetes. It collects data from various pediatric diabetes centers worldwide to evaluate the effectiveness of multidisciplinary treatment approaches. The registry focuses on harmonizing care standards and optimizing outcomes for young patients, ensuring they can fully participate in childhood experiences despite their condition. Data is gathered from local clinical databases and electronic health records, which are then aggregated into a central database for analysis.
Who should consider this trial
Good fit: Ideal candidates include children and adolescents diagnosed with Type 1 Diabetes who can provide informed consent.
Not a fit: Patients without diabetes or those unable to comply with the study protocol may not benefit from this registry.
Why it matters
Potential benefit: If successful, this initiative could lead to improved diabetes management and outcomes for children and adolescents globally.
How similar studies have performed: Other similar registries have shown success in improving diabetes care, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diabetes mellitus (as diagnosed clinically) 2. Males and females of all Ages, but with a focus on pediatric care 3. Provision of informed consent from participant and all legal representatives prior to any study specific procedures Exclusion Criteria: 1. no diabetes 2. no consent, 3. Patient who, in the judgment of the Investigator, is found to be unlikely to comply with the protocol, or has any severe concurrent medical or psychological condition that may affect the interpretation of efficacy or safety data
Where this trial is running
Hanover, Low Saxony
- Kinderkrankenhaus auf der Bult — Hanover, Low Saxony, Germany (Recruiting)
Study contacts
- Principal investigator: Thomas Danne, MD — Kinderkrankenhaus auf der Bult
- Study coordinator: Olga Prof. Kordonouri, MD
- Email: kordonouri@hka.de
- Phone: +49 511 8115 3331
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.